In this episode:
00:00 – Introduction by Paul Rickard
01:32 – Peter Switzer on why it’s time to get more defensive, how to position your portfolio, and the latest on the US market pullback
09:33 – Besa Deda (William Buck) on interest rates: are rate cuts finished, could a hike be next, and what’s driving sticky inflation? Property and share market outlook, plus how to invest for the next 12 months
Get the full story behind the latest stock market pullback—and how you can position your portfolio defensively in uncertain times. Paul Rickard and guests break down why the markets have turned cautious, whether rate cuts are finished, and what it all means for shares, property, and your money.
Dr Ross Walker explains the two main genetic causes of heart disease that make up 90% of cases.
Peter Switzer discusses the latest market developments and what is making him mad in the latest live episode of Mad about Money.
Peter Switzer catches up with Charlie Aitken, Paul Rickard, David Zammit and Russel Pillemer.
Dr Ross Walker explains what makes sudden cardiac death in older people different.
Peter Switzer and Paul Rickard discuss the latest market developments and what is making them really mad in the latest live episode of Mad about Money.
Following the worst day for the Australian sharemarket in over a decade, Peter Switzer speaks to Julia Lee, Michael McCarthy, Charlie Aitken, Paul Rickard and ST Wong to find out how they're responding.
Dr Ross Walker explains what sudden cardiac death is and what you should do if you think you could be at risk.
Join Peter Switzer and Paul Rickard for this week's episode of Mad about Money.
'Old debating enemies' Steve Keen and Chris Joye weigh in on the effects of COVID-19, plus Charlie Aitken and Paul Rickard.
Peter Switzer speaks to Kazia Therepeutics (KZA) CEO James Garner about the company's work to develop a new drug for cancer.
In this week's The Check Up, Dr Ross Walker explains why Vitamins may not be good for you.
For an update on the company's progress in developing a portable brain scanner for detecting stroke, EMvision (ASX: EMV) CEO Dr Ron Weinberger joins Peter Switzer.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox
